Transforming Drug Discovery And Data Integration
Working together to create insights, potential and breakthroughs
Partnership and Collaboration Models
We partner with top-tier pharmaceutical and technology companies to solve the greatest drug discovery challenges of today. We are on a mission to transform the pace and precision of antibody discovery, aiming to develop safer, more effective biologics for better patient outcomes.
Solve the Complex: our mission is solutions
An end-to-end fusion of in vitro, in vivo and in silico technologies in conjunction with our parent company IPA
Enrich candidate diversity
Optimizing your IP and clinical success
De-risk at every stage
Customized target analysis, discovery expansion, candidate characterization and lead optimization
Data-driven decision making
Advanced data integration platform (text, sequence, structure, function) with unlimited scalability supporting critical decisions
Reduce costs
Designed to solve the complex with less effort and accelerated timelines
Change your cycle of acceleration
Uncover rapid deep biologic insights aimed at shorter pre-clinical timelines
Make all data useful
Integrate or benchmark new or existing data with patented HYFT® technology to uncover novel solutions
“Today is an exciting time for advancing AI and drug discovery. Join us in paving the way. Through strategic collaborations, we develop innovative solutions for pharma and tech innovators, researchers, and developers. By tackling the most complex challenges and appreciating the uniqueness of each initiative, we drive transformative breakthroughs in life sciences.”
Dirk Van Hyfte, MD, PhD
Head of Innovation
LENSai™ powered by HYFTS - the great connector for clinical success
Integrating multi-omics data enables unlimited scalability, continuous data indexing, and profound insights. Our end-to-end platform provides a single view connecting sequence, structure, function, and text, ensuring traceable data back to its source.